A cautionary tale of an emergency cerebrovascular procedure in the COVID-19 era

Hossam Abdou1, Besher Tolaymat2, Felecia Jinwala2

  • 1Department of Surgery, University of Maryland Medical Center, Baltimore, Md.

Insights

A patient experienced anaphylaxis to sugammadex after carotid endarterectomy. Delayed reintubation due to institutional policies highlights risks in critical care during the COVID-19 pandemic.

Area of Science:

  • Anesthesiology
  • Critical Care Medicine
  • Neurology

Background:

  • The COVID-19 pandemic significantly impacted healthcare system processes, particularly airway management.
  • Stroke patients require urgent surgical intervention, such as carotid endarterectomy, for effective treatment.

Observation:

  • A 37-year-old female stroke patient developed anaphylaxis upon extubation following a carotid endarterectomy.
  • The anaphylactic reaction was attributed to sugammadex, a neuromuscular reversal agent.
  • Institutional policies and resource limitations led to a delay in reintubation.

Findings:

  • Despite the delay, the patient experienced no lasting neurological deficits.
  • The case underscores the potential for existing healthcare policies to precipitate adverse events in critical care settings.
  • Sugammadex-induced anaphylaxis can pose a significant challenge in emergency surgical scenarios.

Implications:

  • There is a critical need to review and revise institutional policies to prevent delays in essential procedures like reintubation.
  • Healthcare systems must adapt to manage rare but severe complications, such as sugammadex anaphylaxis, especially during public health crises.
  • Improving airway management protocols and resource allocation is crucial for patient safety in neurovascular surgery.